PURR.AI’s Post

🚀 Excited to share insights from the NVIDIA GTC March 2024 Keynote with CEO Jensen Huang! Just finished listening to it. 🎉 Dive into the groundbreaking advancements in computer-aided drug discovery with NVIDIA BioNeMo's expanded #generativeAI toolkit. 💊 🔬 Discover how BioNeMo's foundation models analyze DNA sequences, predict protein shape changes, and determine cell function based on #RNA. 🧬 These models, available through NVIDIA NIM and soon on Amazon Web Services (AWS) HealthOmics, revolutionize drug discovery by integrating generative AI into workflows. 💡 💻 Explore new microservices like EquiDock, DiffDock, and ESMFold, enabling predictive protein structure analysis and drug candidate optimization. 💡 These AI insights are accessible via NVIDIA AI Enterprise on-premises and leading cloud marketplaces. 🌐 👩🔬 100+ companies, including Astellas Pharma, Insilico Medicine, and Recursion, leveraging BioNeMo to accelerate drug discovery. 🌟1️⃣ Astellas Pharma: Using BioNeMo to accelerate molecular simulations and LLMs for drug discovery applications. The company will use the Tokyo-1 AI supercomputer to further advance its work. 🌟2️⃣ Cadence: It is integrating BioNeMo microservices with its Orion platform to accelerate molecular simulation. 🌟3️⃣ Iambic Therapeutics : Has adopted BioNeMo and will contribute its NeuralPLexer model as a BioNeMo cloud API, or application programming interface, for noncommercial use, helping researchers predict how a protein’s 3D structure changes in response to a drug molecule. 🌟4️⃣ Insilico Medicine: It has integrated BioNeMo in its AI-accelerated drug discovery workflow, developing a pipeline of over 30 therapeutic assets including six in clinical stages. 🌟5️⃣ Recursion: It is a hosting partner offering its Phenom-Beta AI model through BioNeMo. The transformer model extracts insights from cellular microscopy images to help researchers better understand cell function. 🌟6️⃣ Terray Therapeutics: It is using BioNeMo to help develop a multi-target structural binding model & is training generative AI models for small molecule design on NVIDIA DGX Cloud. 🌟 As a medical physician and AI leader, I'm thrilled about the transformative potential of these advancements in healthcare. 🩺 #NVIDIA #BioNeMo #AI #DrugDiscovery #Healthcare #MedicalAI #ArtificialIntelligence #Technology #Innovation #GTC2024 #GenerativeAI #ProteinDesign #Microservices #Research #Leadership #MedicalLeadership #Pharmaceuticals #ComputationalBiology #Biotechnology #HealthTech #LifeSciences #Startups #MNCs Discover the latest in #AI and #healthcare at GTC, a global AI conference running in San Jose, Calif., and online through Thursday, March 21. Tune in to a special address on generative AI in healthcare delivered by Kimberly Powell, vice president of healthcare at NVIDIA. "GTC March 2024 Keynote with NVIDIA CEO Jensen Huang"

We had Tech and Biotech... Came along TechBio... In the last 24/36 months, TechBio has been integrating with BioTech. Now... we have pure Tech / Hardware manufacturers (such as Jensen Huang's NVIDIA) going into TechBio and BioTech... NVIDIA is aiming to build an "AI foundry" for multiple industries, of which Biotech. It is a bold move but Jensen Huang as proven many times not to be shy of a challenge. Interesting to note that NVIDIA has already bought a significant minority stake in Recursion. In business strategy, there is never a swift transition and there is never a spotless cross-sector business integration. Integrating hardware and software approaches may not be easy. Be sure to follow my friend's Andrew Dunn's new Post-Hoc Endpoints News' newsletter on this topic (➡ https://lnkd.in/dnNuFzQy). I will. It will be fascinating to follow what happens across these industries and how it will affect drug development. The future holds great promises. #biotech #techbio #businessdevelopment #AI https://lnkd.in/dh3VYT2N

To tackle more unsolved mysteries in healthcare with artificial intelligence, remain true to our mission of curing the incurable, and sustain our passion for longevity, we are always striving for excellence. As part of this commitment, we have upgraded our high-performance supercomputing infrastructure by adding a few NVIDIA #H100 #GPU servers. Check out the video of us unboxing these powerful NVIDIA H100 GPU servers!

🚀 Exciting News from Nostrum Biodiscovery! 🚀 We're thrilled to share that Nostrum Biodiscovery has been accepted into the NVIDIA Inception program! This marks a significant milestone in our journey to revolutionize health and technology through artificial intelligence. NVIDIA is at the forefront of AI and graphics processing, and this collaboration opens up incredible opportunities. By joining NVIDIA Inception, we're aiming to: ●     Enhance the efficiency of pharmaceutical methods 🧬 ●     Revolutionize drug discovery with AI-enhanced molecular modeling 🤖 ●     Drive innovation in biotech and AI 🌐 This is more than a collaboration; joining NVIDIA Inception will help us accelerates our mission to integrate molecular modeling with AI, turning complex designs into innovative solutions more rapidly and leveraging the latest advancements in health and technology. A huge thank you to our team, our partners, and everyone who's been a part of our journey so far. We can't wait to see where this collaboration with NVIDIA will take us! Stay tuned for updates and let's make the future of health and technology brighter, together. #NVIDIAInception #AI #HealthTech #Innovation

🚀 Evariste x NVIDIA Inception 🚀 We're thrilled to announce that Evariste has joined NVIDIA Inception, a program that supports young companies transforming industries with their technological advancements. We firmly believe that the support provided by NVIDIA will enhance the capabilities of Frobenius, our AI-enabled drug discovery platform, which excels at working with small and noisy biological datasets to identify novel blockbuster synthetic lethal targets and discover best-in-class small molecule therapeutics. As part of Inception, we will have access to NVIDIA's cutting-edge technology, expertise, and a network of like-minded teams. We are particularly excited about the support for our future exploratory research projects, which involve computationally intensive tasks. Technical assistance and access to cloud compute credits from NVIDIA will be invaluable for these projects. This development comes at an exciting time for Evariste, with promising preclinical data coming in for our lead #PKMYT1 program, as well as rapidly progressing early programs, which all serves as crucial proof-of-concept for Frobenius. If you would like to join us on our journey to transform drug discovery as a partner or an investor, we would love to hear from you! Stay tuned for more updates. 🕑 #Evariste #NVIDIAInception #AIDrugDiscovery #SyntheticLethality #TechBio

Nvidia, known for its gaming chips, is now eyeing the lucrative healthcare market, worth a whopping $4.7 trillion in the U.S. The company has already made significant strides, teaming up with industry giants like Johnson & Johnson and GE Healthcare to integrate AI into surgeries and improve medical imaging. With these moves, Nvidia is poised to revolutionize healthcare technology. For details tap the link in bio #Nvidia #Healthcare #AI #Innovation #Technology #JohnsonAndJohnson #GEHealthcare #MedicalImaging #SurgicalAI

Cadence and NVIDIA, unveiling GenAI and accelerated compute-driven innovations. This partnership aims to revolutionize the fields of artificial intelligence and accelerated computing, leveraging Cadence's expertise in electronic design automation and NVIDIA's prowess in GPU-accelerated computing. The introduction of GenAI promises to drive unprecedented advancements in AI model development and deployment, empowering organizations to harness the full potential of AI-driven insights. With this collaboration, Cadence and NVIDIA are poised to redefine the landscape of AI and computing, paving the way for transformative innovations across industries. https://lnkd.in/gZ8nbDTS #ExpressComputer #Cadence #NVIDIA #GenAI #AcceleratedComputing #Innovations #AI #ArtificialIntelligence #ElectronicDesignAutomation #GPUComputing #TechCollaboration #UnderstandingEnterpriseTech #EnterpriseTechnologyNow #EnterpriseTechnologyToday

This 👇 is what I'm talking about regarding using #AI tools in complex #chip_design.

🚀💥 NVIDIA IS JUST UNBELIEVABLE 😳🔥 Introducing Mikkel Østergaard, Our AI correspondent, reporting live from the DataGlobal Hub studio in Northern Europe (Denmark). Today’s headline: #Denmark Unveils Gefion: A New AI Supercomputer Powered by NVIDIA to Drive Global Innovation Did You Know? Denmark’s AI Revolution has been brought about by NVIDIA⁉️ Denmark has just unleashed #Gefion, a groundbreaking supercomputer with 1,528 NVIDIA H100 GPUs, setting the stage for a global AI revolution. Gefion, launched in Copenhagen, will drive innovations across healthcare, life sciences, green technology, and quantum computing. This powerhouse was made possible through a dynamic public-private partnership, led by the Novo Nordisk Foundation and Denmark’s Export and Investment Fund. But it doesn’t stop there! NVIDIA’s visionary CEO, Jensen Huang , joined Danish Centre for AI Innovation (DCAI) , Nadia Carlsten, PhD in a captivating fireside chat on why Denmark is now at the cutting edge of AI, and even The King of Denmark (King Frederick X of Denmark) attended, highlighting how monumental this is for the nation’s tech journey. Gefion isn’t just a tool; it’s an open invitation to innovators worldwide—from startups to researchers—to leverage its potential and redefine what AI can achieve. With workshops, lectures, and community events, the Danish Centre for AI Innovation (DCAI) will make Gefion a vibrant hub of global collaboration. Stay tuned as Gefion sets the stage for next-gen breakthroughs. The future of AI is now, and Denmark is taking charge! #AIRevolution #GefionSupercomputer #InnovationDenmark #GlobalTechHub #NVIDIA #HealthcareInnovation #GreenTech #QuantumComputing #FutureOfAI #DanishInnovation #DCAI

Hello everyone, We are currently four parts into this series, and I welcome you to the fifth installment of Insights Unbound, where we will delve into interesting industry trends and news that have caught my eye. This week, I am eager to discuss NVIDIA's incredible journey and recent achievements🏆. Nvidia has demonstrated exceptional performance, outperforming investor expectations with record-breaking revenues💰. This success according to my analysis, stems from strategic dissonance—a dynamic shift in their core focus towards AI and data-centric capabilities🤖. By identifying and navigating this inflection point, Nvidia capitalized on emerging trends and leveraged their dynamic capabilities to stay ahead🥇. Join me as I analyse Nvidia’s strategic manoeuvres, financials, the factors driving their success, and future industry trends that could shape their trajectory.📈 A big thank you to my friends Rudra Banerjee and Siddhant Bhagat for their support and insights. Remember to share your insights and comments🎙️ #NVIDIA #InsightsUnbound #Strategy #Trends #news #BusinessTrends